ORIFARM SUPPLY A/S: Financial statements 2020
CVR: 17153684
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
ORIFARM SUPPLY A/S (CVR 17153684) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 7,025,289,000 and a net result of DKK 173,456,000 compared with DKK 164,376,000 the year before. That is an increase of 11.5% compared with the year before. The profit margin was 2.5%. Equity in the 2020 report amounted to DKK 546,723,000. The solvency ratio was 40.8%. The company had 109 employees in the financial year.
- Revenue
- DKK 7,025,289,000
- Gross Profit
- DKK 301,666,000
- Profit/Loss
- DKK 173,456,000
- Equity
- DKK 546,723,000
- Total Assets
- DKK 1,340,870,000
- Employees
- 109
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 7B | 301.7M | 173.5M | 546.7M | 109 |
| 2019 | 6.3B | 282M | 164.4M | 502.6M | 104 |
| 2018 | 5.4B | 238.3M | 126M | 428.1M | 89 |
| 2017 | 5B | 180.6M | 86.2M | 334.5M | 80 |
| 2016 | 4.7B | 111.6M | 41.7M | 246.1M | 46 |
Official annual report
How creditworthy is ORIFARM SUPPLY A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
ORIFARM SUPPLY A/S has published its annual report for 2019. Revenue came to DKK 6,301,721,000, and the net result was DKK 164,376,000.
About ORIFARM SUPPLY A/S
ORIFARM SUPPLY A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 1993. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MEDIPACK A/S and SBH2 ApS. The management consists of Mads Fink Eriksen. The board consists of Ole Michael Friis (chair), Birgitte Bøgh-Sørensen, Hans Carl Bøgh-Sørensen and Nicki Lund Kristensen. The company is owned by MEDIPACK HOLDING A/S. The company has 188 employees (2026). In 2025, the company reported revenue of DKK 11,714,817,000 and a net result of DKK 253,440,000 compared with DKK 269,398,000 the year before. Equity in the 2025 report amounted to DKK 1,337,548,000.